MB Marinomed Biotech AG Stock: price and directors' dealings · Austria · FMA (OeKB OAM)Track the Marinomed Biotech AG share price and the full management transaction log of the company, a listed issuer based in Austria. Shares are listed on the AT market, under the supervision of FMA (OeKB OAM). Operating in the Healthcare & Pharma sector, Marinomed Biotech AG has published 28 reports. Market capitalisation: €9.4m. The latest transaction was disclosed on 15 April 2026 (Purchase). Among the most active insiders: Brigitte Ederer. Every trade is free.
Fundamental score
Ranked 4,043 of 29,064 companies
FCF yld -12%
Earn yld ·
EV/EBITDA 1.1x
ROE ·
Gross mgn 82%
Net mgn ·
Debt/EBITDA 0.6x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 April 2026
All Executives28 Thresholds0 Prospectus0 Other0
Declarations 28 total
● Member of the managing body · Executives · 13 Apr 2026
357 shares @ €14.00 0.053% mcap 1.1% of flow Share ISIN ISIN ATMARINOMED6FMA:247695 ● Executives
Executives · 15 Apr 2026
● Member of the managing body · Executives · 13 Apr 2026
357 shares @ €14.00 0.053% mcap 1.1% of flow Share ISIN ISIN ATMARINOMED6FMA:247691 ● Executives
Executives · 15 Apr 2026
1,500 shares @ €14.00 0.22% mcap 50.0% of flow Share ISIN ISIN ATMARINOMED6FMA:247198 ● Aufsichtsrat b) Erstmeldung/Berichtigung Erstmeldung · Executives · 31 Mar 2026
1,500 shares @ €14.00 33.3% of flow Share ISIN ISIN ATMARINOMED6FMA:247196 3,521 shares @ €14.00 0.52% mcap 66.1% of flow Share ISIN ISIN AT0000A3T5H4FMA:247194 ● Meldepflichtige Person steht in enger Beziehung zu: Simon Nebel, Aufsichtsrat · Executives · 31 Mar 2026
3,521 shares @ €14.00 0.52% mcap 39.8% of flow Share ISIN ISIN AT0000A3T5H4FMA:247192 33,032 shares @ €14.00 4.92% mcap 98.9% of flow Share ISIN ISIN AT0000A3T5H4FMA:247190 ● Executives
Executives · 31 Mar 2026
33,032 shares @ €14.00 4.92% mcap 98.9% of flow Share ISIN ISIN AT0000A3T5H4FMA:247186 7,885 shares @ €14.70 1.23% mcap 100.0% of flow Share ISIN ISIN ATMARINOMED6FMA:217081 ● Member of the administrative or supervisory · Executives · 8 Jan 2025
1,500 shares @ €14.00 0.22% mcap 50.0% of flow Share ISIN ISIN ATMARINOMED6FMA:216982 ● Member of the administrative or supervisory · Executives · 18 Sept 2024
5,053 shares @ €5.00 0.27% mcap 33.9% of flow Share ISIN ISIN ATMARINOMED6FMA:204313 ● Member of the Supervisory Board b) Initial notification · Executives · 20 Apr 2023
5,634.4 shares @ €37.5627 2.25% mcap 0.1% of flow Share Vienna Stock Exchange MICISIN ISIN ATMARINOMED6FMA:187466 ● Member of Supervisory Board b) Amendment Correction of the aggregated · Executives · 15 Sept 2022
6,320 shares @ €63.20 4.25% mcap 0.2% of flow Share Vienna Stock Exchange MICISIN ISIN ATMARINOMED6FMA:178676 ● Member of Supervisory Board b) Initial notification · Executives · 15 Sept 2022
632,000 shares @ €63.20 20.2% of flow Share Vienna Stock Exchange MICISIN ISIN ATMARINOMED6FMA:178670 ● Member of Advisory Board b) Initial notification · Executives · 15 Dec 2021
1,772,340 shares @ €88.617 79.5% of flow Share Vienna Stock Exchange MICISIN ISIN ATMARINOMED6FMA:166067 ● CFO b) Initial notification · Executives · 2 Dec 2021
16,200 shares @ €90.00 15.52% mcap 50.9% of flow Share Outside a trading venue NewsISIN ISIN ATMARINOMED6FMA:165265 ● CFO b) Initial notification · Executives · 16 Dec 2020
18,750 shares @ €75.00 49.1% of flow Share Outside a trading venue NewsISIN ISIN ATMARINOMED6FMA:149376 ● Executives
Executives · 27 Jan 2020
● Executives
Executives · 18 Oct 2019
● Executives
Executives · 22 Feb 2019
● Executives
Executives · 22 Feb 2019
● Executives
Executives · 5 Feb 2019
25 of 28 declarations
Load more (3 remaining) 关于 Marinomed Biotech AG Marinomed Biotech AG 是一家生物制药公司,专注于开发抗病毒治疗和疫苗。它专门为病毒性疾病和呼吸道感染提供创新解决方案。